CG
UBIO

Cutler Group’s Proshares UltraPro NASDAQ Biotechnology UBIO Stock Holding History

Cutler Group’s Portfolio UBIO Stock Details UBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-4,500
Closed -$4K – 4941
2019
Q3 		$4K Buy
+4,500
New +$101K ﹤0.01% 3245
2019
Q2 		– Sell
-4,000
Closed -$4K – 5077
2019
Q1 		$4K Buy
4,000
+3,000
+300% +$85.1K ﹤0.01% 3121
2018
Q4 		$6K Sell
1,000
-800
-44% -$22.6K ﹤0.01% 2883
2018
Q3 		$4K Buy
+1,800
New +$72.7K ﹤0.01% 3258
2018
Q2 		– Sell
-1,300
Closed -$3K – 5226
2018
Q1 		$3K Buy
+1,300
New +$47.8K ﹤0.01% 3673
2017
Q2 		– Sell
-3,400
Closed -$4K – 7459
2017
Q1 		$4K Sell
3,400
-2,700
-44% -$71.1K ﹤0.01% 5002
2016
Q4 		$34K Buy
6,100
+5,500
+917% +$130K ﹤0.01% 2937
2016
Q3 		$1K Buy
600
+300
+100% +$8.54K ﹤0.01% 6442
2016
Q2 		$1K Hold
300
– – ﹤0.01% 6415
2016
Q1 		$7K Sell
300
-700
-70% -$19.3K ﹤0.01% 4550
2015
Q4 		$2K Buy
+1,000
New +$52.9K ﹤0.01% 5727

Other funds holding UBIO

Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Cutler Group's UBIO Position: Q1 2020 in Review

Cutler Group sold out of Proshares UltraPro NASDAQ Biotechnology (UBIO) in Q1 2020, closing a stake of 1,521 shares — an estimated $49K sold.

Cutler Group first reported a position in UBIO in Q4 2015 and held it in 10 quarters. The position peaked at $171K in Q4 2015. 1 fund tracked by Wall St. Rank holds UBIO as of Q1 2020.

  • Cutler Group reported no remaining Proshares UltraPro NASDAQ Biotechnology position as of Q1 2020 after selling out during the quarter.
  • Cutler Group sold 1,521 Proshares UltraPro NASDAQ Biotechnology shares in Q1 2020, an estimated $49K.
  • Cutler Group first reported a position in Proshares UltraPro NASDAQ Biotechnology in Q4 2015 and held it in 10 quarters.
  • Cutler Group's Proshares UltraPro NASDAQ Biotechnology position peaked at $171K in Q4 2015.
  • 1 fund tracked by Wall St. Rank held Proshares UltraPro NASDAQ Biotechnology as of Q1 2020.

Based on Cutler Group's 13F filing for Q1 2020, filed 7 May 2020.